UA102145C2 - Иммуногенная композиция, которая содержит lawsonia intracellularis - Google Patents

Иммуногенная композиция, которая содержит lawsonia intracellularis

Info

Publication number
UA102145C2
UA102145C2 UAA201111797A UAA201111797A UA102145C2 UA 102145 C2 UA102145 C2 UA 102145C2 UA A201111797 A UAA201111797 A UA A201111797A UA A201111797 A UAA201111797 A UA A201111797A UA 102145 C2 UA102145 C2 UA 102145C2
Authority
UA
Ukraine
Prior art keywords
immunogenic compositions
prophylaxis
treatment
lawsonia intracellularis
avirulentisolate
Prior art date
Application number
UAA201111797A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джереми Кроулл
Майк РУФ
Original Assignee
Берингер Ингельхайм Ветмедика, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Ветмедика, Инк. filed Critical Берингер Ингельхайм Ветмедика, Инк.
Publication of UA102145C2 publication Critical patent/UA102145C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Изобретение относится к комбинации, которая содержит авирулентный изолят, ослабленнуюи ослабленнуюпредназначеннойдля применения в качестве лекарственного средства, а также к способу профилактики или лечения заболеваний, вызванныхилииликоторый включает введение животному, которое в этом нуждается, i) авирулентного изолятаи ii) ослабленнойимеющей эффективность относительно лечения и/или профилактики инфекции, вызваннойи iii) ослабленнойимеющей эффективность относительно лечения и/или профилактики инфекции, вызванной.
UAA201111797A 2005-03-14 2006-03-14 Иммуногенная композиция, которая содержит lawsonia intracellularis UA102145C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66135205P 2005-03-14 2005-03-14

Publications (1)

Publication Number Publication Date
UA102145C2 true UA102145C2 (ru) 2013-06-10

Family

ID=38687232

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201111797A UA102145C2 (ru) 2005-03-14 2006-03-14 Иммуногенная композиция, которая содержит lawsonia intracellularis
UAA200711236A UA97785C2 (ru) 2005-03-14 2006-03-14 Иммуногенные композиции, которые содержат lawsonia intracellularis

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200711236A UA97785C2 (ru) 2005-03-14 2006-03-14 Иммуногенные композиции, которые содержат lawsonia intracellularis

Country Status (2)

Country Link
RU (1) RU2443430C2 (ru)
UA (2) UA102145C2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2629399C1 (ru) * 2016-08-08 2017-08-29 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Способ профилактики африканской чумы свиней

Also Published As

Publication number Publication date
RU2443430C2 (ru) 2012-02-27
UA97785C2 (ru) 2012-03-26
RU2007137984A (ru) 2009-04-20

Similar Documents

Publication Publication Date Title
UA100507C2 (ru) Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd)
BRPI0608439A2 (pt) composições imunogênicas compreendendo lawsonia intracellularis
MX2009006541A (es) Tratamiento de prdc en cerdos.
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
MX2009006066A (es) Tratamiento de cerdos con el antigeno pcv.
UA93201C2 (ru) АНТИТЕЛО, KOTOPOE НЕЙТРАЛИЗУЕТ ЧЕЛОВЕЧЕСКИЙ TGF-b1
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
MXPA06005639A (es) Adyuvante antimicrobiano.
UA104129C2 (ru) Уменьшение сопутствующих инфекций у свиней с помощью антигена pcv2
WO2008073464A3 (en) Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
EP1880719A3 (en) Composition for prophylaxis or treatment of urinary system infection and method thereof
IN2012DN00829A (ru)
GB2434983A (en) Methods and compositions for wound healing
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ATE537819T1 (de) Nutrazeutische zusammensetzungen zur behandlung von muskelschwund
TW200744631A (en) Lawsonia vaccine and methods of use thereof
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
PL1965809T3 (pl) Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany
NO20070746L (no) Anvendelse av fosfaterte alkanoler som dispergente , emulgatorer, hydrotroper, fuktmidler og kompatabilitetsstoffer i blandinger for jordbruket.
WO2008150275A3 (en) Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection
WO2008105826A3 (en) Compositions compromising lysostaphin variants and methods of using the same
WO2008005059A3 (en) Treatment of mouth and urinary tract infections
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy